Harmony Biosciences Holdings Stock Story
| HRMY Stock | USD 29.03 0.16 0.55% |
Slightly above 55% of Harmony Biosciences' investor base is interested to short. The analysis of overall sentiment of trading Harmony Biosciences Holdings stock suggests that many investors are impartial at this time. Harmony Biosciences' investor sentiment overview provides quick insight into current market opportunities from investing in Harmony Biosciences Holdings. The current market sentiment, together with Harmony Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Harmony Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Harmony Biosciences stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Harmony daily returns and investor perception about the current price of Harmony Biosciences Holdings as well as its diversification or hedging effects on your existing portfolios.
Harmony |
Requested story not found. it has been either deleted or moved. View all stories for Harmony Biosciences Holdings.
Harmony Biosciences Latest Timeline
Harmony Biosciences is listed for 29.03. The company reported the previous year's revenue of 582.02 M. Net Income was 128.85 M with profit before overhead, payroll, taxes, and interest of 354.37 M.Check out Harmony Biosciences Hype Analysis, Harmony Biosciences Correlation and Harmony Biosciences Performance. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Harmony Stock analysis
When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is Harmony Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harmony Biosciences. If investors know Harmony will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harmony Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share 2.13 | Revenue Per Share 9.787 | Quarterly Revenue Growth 0.313 | Return On Assets 0.1616 |
The market value of Harmony Biosciences is measured differently than its book value, which is the value of Harmony that is recorded on the company's balance sheet. Investors also form their own opinion of Harmony Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Harmony Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harmony Biosciences' market value can be influenced by many factors that don't directly affect Harmony Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harmony Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Harmony Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harmony Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.